Evidence map›Paper›PMID 17611588›Full record

ArticleGene therapy2007

Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice.

S-K Hwang, H Jin, J T Kwon, S-H Chang, T H Kim, C-S Cho, K H Lee, M R Young, N H Colburn, G R Beck and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions.International journal of molecular sciences · 2019
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death.Proceedings of the National Academy of Sciences of the United States of America · 2011
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

S-K HwangLaboratory of Toxicology, College of Veterinary Medicine, Seoul National University, Seoul, Korea.
H Jin
J T Kwon
S-H Chang
T H Kim
C-S Cho
K H Lee
M R Young
N H Colburn
G R Beck
H-S Yang
M-H Cho
Seoul National University · KRNational Cancer Institute · USEmory University · USKorea Institute of Radiological and Medical Sciences · KRUniversity of Kentucky · US

Funding

The Role of Pdcd4 in Translation, Tumorigenesis and Tumor ProgressionZIABC010026 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI COLBURN, NANCY H. · 2009 to 2013
$2.7M
The Role of Pdcd4 in Translation, Tumorigenesis and Tumor ProgressionZ01BC010026 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI COLBURN, NANCY H. · 1996 to 2008
$1.5M
ROLE OF P270 IN DIFFERENTIATION AND TUMORIGENESISK22CA084573 · NCI · EMORY UNIVERSITY · PI BECK, GEORGE R. · 2005 to 2006
$310k
NCI NIH HHS CA84573
6 · The paper itself

Abstract

The long-term survival of lung cancer patients treated with conventional therapies remains poor and therefore the need for novel approaches remains high. This has led to the re-emergence of aerosol delivery as a therapeutic intervention. In this study, glucosylated polyethylenimine (GPEI) was used as carrier to investigate programmed cell death 4 (PDCD4) and PDCD4 mutant (D418A), an eIF4A-binding mutant, on PDCD4-related signaling and activator protein-1 (AP-1) activity in the lungs of AP-1 luciferase reporter mice. After confirming the efficiency of GPEI as a carrier in lungs, the effects of aerosol-delivered PDCD4 were investigated in AP-1 luciferase reporter mice. Aerosol delivery of GPEI/PDCD4 through a nose-only inhalation facilitated the apoptosis of lungs whereas aerosol PDCD4 mutant did not. Also, such aerosol delivery regulated proteins relevant to cell-cycle control and suppressed AP-1 activity. Results obtained by western blot analysis, immunohistochemistry, luciferase assay and deoxynucleotidyl-transferase-mediated nick end labeling study suggest that combined actions such as facilitating apoptosis, controlling cell cycle and suppression of AP-1 activity by PDCD4 may provide useful tool for designing lung tumor prevention and treatment by which PDCD4 functions as a transformation suppressor in the future.

Indexed as

AerosolsAnimalsApoptosisApoptosis Regulatory ProteinsCell CycleGene ExpressionGenetic TherapyImmunohistochemistryIn Situ Nick-End LabelingLuciferasesLungLung NeoplasmsMiceMice, Inbred C57BLMice, Inbred DBAModels, AnimalAerosolsApoptosis Regulatory ProteinsLuciferasesPdcd4 protein, mousePolyethyleneimineRNA-Binding ProteinsTranscription Factor AP-1

Identifiers

PMID17611588
OpenAlexW2070300401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.